Baker Tilly Wealth Management LLC Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Baker Tilly Wealth Management LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,211 shares of the healthcare conglomerate’s stock after selling 153 shares during the period. Baker Tilly Wealth Management LLC’s holdings in UnitedHealth Group were worth $613,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $32,000. Quarry LP raised its stake in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares in the last quarter. Finally, VitalStone Financial LLC lifted its stake in UnitedHealth Group by 600.0% in the second quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock worth $36,000 after purchasing an additional 60 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on UNH shares. Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Stock Up 0.7 %

UNH stock traded up $3.48 during trading on Friday, hitting $528.00. 1,571,818 shares of the stock traded hands, compared to its average volume of 3,514,637. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a market cap of $485.91 billion, a price-to-earnings ratio of 34.40, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s 50 day moving average is $556.20 and its two-hundred day moving average is $561.20.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the company earned $6.56 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.59%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.